Recruiting

Observational Study

Sponsor:

The University of Texas Health Science Center, Houston

Code:

NCT00857922

Conditions

Neurological Conditions

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Accepted

Interventions

tissue and data repository

Study Details

Brief summary:

In order to expand neuroscience research and move laboratory advances to patients, there is a need to integrate reliable clinical data with biologic information from patient tissue specimens. The Neuroscience Research Repository (NRR) seeks to meet this need. The NRR is a prospective database and sample bank created to collect information and samples for current and future neuroscience research. The objective of this NRR is to develop a data and sample repository for study of neurological conditions. A repository utilizing standardized electronic health data and samples collected in a uniform manner serves to foster the ability to perform research on current and future projects. Samples and data for clinical, genomic and proteomic analysis will be provided to optimize their value for neuroscience research.

The NRR will enroll patients and collect clinically recorded longitudinal data for as long as they are followed by the Neurosurgery service and up to an additional 5 years after being released from care. Patients will be enrolled on admission to the service and samples will be taken at three time points: Time One, within 24 hours of event (preferably first blood draw); Time Two, within 48 hours of event; and Time Three, time of any residual tissue availability. Family members of select groups of patients will also be approached for enrollment.

Samples and data will be labeled with a study code to maintain confidentiality. Samples and data will be maintained in secure, limited access environments with back-up/redundancy procedures in place. Sample inventory will be maintained with a bar-coding system. A duty to warn clause will be included in the consent as will the determination of willingness to be re-contacted for future research. Time of sample acquisition to time of sample processing will be documented for quality control purposes. Freezers will be monitored for temperature stability. Recipient investigators will be requested to provide feedback on sample quality. Samples will be distributed to neuroscience investigators after approval from the Neurosurgery Scientific Review Committee - Dissemination Review Committee and the Committee for the Protection of Human Subjects (CPHS).

Conditions

Neurological Conditions

Study ID

NCT00857922

Start date

Mar, 2009

Status verified date

Jun, 2026

Completion date

Aug, 2030

Anticipated

Primary completion date

Mar, 2030

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Accepted

Inclusion Criteria:

1. Neurosurgical patient (primary or consulting); patients<18 includes residual tissue only, no blood samples.
2. Family members of specific vascular, trauma, brain tumor and functional disorder cohorts (will be identified in future addendums to this repository)

Exclusion Criteria:

1\. Inability to obtain informed consent

Study Design

Enrollment

15000 participants

Anticipated

Interventions and Outcome Measures

Arms

Neurosurgical patient

Neurosurgical patient of the Mischer Neuroscience Institute, 18 years and over

Family members

Family members of specific vascular, trauma, brain tumor and functional disorder cohorts

Interventions

tissue and data repository

Tissue and data will be maintained in a repository for study from consenting subjects.

Primary outcome measure

  • Discharge status [ Time Frame: hospital discharge ]

Central Contacts and Locations

Central contacts

Locations

Memorial Hermann Hospital

Recruiting

Houston, Texas, United States, 77030

More Information

Sponsor

The University of Texas Health Science Center, Houston

Last update posted

Jun 16, 2026

Last verified

Jun, 2026

Keywords

  • Neurological
  • Neurosurgical

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by The University of Texas Health Science Center, Houston on 2026-06-16.